These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 27639260)
41. A population pharmacokinetic model of vancomycin for dose individualization based on serum cystatin C as a marker of renal function. Liu TT; Pang HM; Jing L; Wei WX; Qin XL; Guo Q; Lu H; Cheng DH; Jiang WZ J Pharm Pharmacol; 2019 Jun; 71(6):945-955. PubMed ID: 30873627 [TBL] [Abstract][Full Text] [Related]
42. Pharmacokinetics of cefotaxime and desacetylcefotaxime in infants during extracorporeal membrane oxygenation. Ahsman MJ; Wildschut ED; Tibboel D; Mathot RA Antimicrob Agents Chemother; 2010 May; 54(5):1734-41. PubMed ID: 20176908 [TBL] [Abstract][Full Text] [Related]
43. β-Lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: A case-control study. Donadello K; Antonucci E; Cristallini S; Roberts JA; Beumier M; Scolletta S; Jacobs F; Rondelet B; de Backer D; Vincent JL; Taccone FS Int J Antimicrob Agents; 2015 Mar; 45(3):278-82. PubMed ID: 25542059 [TBL] [Abstract][Full Text] [Related]
44. Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration. Escobar L; Andresen M; Downey P; Gai MN; Regueira T; Bórquez T; Lipman J; Roberts JA Int J Antimicrob Agents; 2014 Aug; 44(2):163-7. PubMed ID: 24837847 [TBL] [Abstract][Full Text] [Related]
45. [Population pharmacokinetics of vancomycin from severe in patients with lower respiratory tract infection]. Yang W; He B; Deng CH Zhonghua Jie He He Hu Xi Za Zhi; 2017 Mar; 40(3):205-209. PubMed ID: 28297816 [No Abstract] [Full Text] [Related]
46. Factors Influencing Norvancomycin Concentration in Plasma and Cerebrospinal Fluid in Patients After Craniotomy and Dosing Guideline: A Population Approach. Li X; Wu Y; Sun S; Wang Q; Zhao Z Clin Ther; 2018 Jan; 40(1):74-82.e1. PubMed ID: 29229228 [TBL] [Abstract][Full Text] [Related]
48. Plasma and cerebrospinal fluid population pharmacokinetics of vancomycin in postoperative neurosurgical patients after combined intravenous and intraventricular administration. Li X; Sun S; Ling X; Chen K; Wang Q; Zhao Z Eur J Clin Pharmacol; 2017 Dec; 73(12):1599-1607. PubMed ID: 28849406 [TBL] [Abstract][Full Text] [Related]
49. Population pharmacokinetic parameters of vancomycin in critically ill patients. Llopis-Salvia P; Jiménez-Torres NV J Clin Pharm Ther; 2006 Oct; 31(5):447-54. PubMed ID: 16958822 [TBL] [Abstract][Full Text] [Related]
50. Hospitalized Patients With and Without Hemodialysis Have Markedly Different Vancomycin Pharmacokinetics: A Population Pharmacokinetic Model-Based Analysis. Goti V; Chaturvedula A; Fossler MJ; Mok S; Jacob JT Ther Drug Monit; 2018 Apr; 40(2):212-221. PubMed ID: 29470227 [TBL] [Abstract][Full Text] [Related]
51. Population pharmacokinetics of vancomycin in adult Chinese patients with post-craniotomy meningitis and its application in individualised dosage regimens. Lin WW; Wu W; Jiao Z; Lin RF; Jiang CZ; Huang PF; Liu YW; Wang CL Eur J Clin Pharmacol; 2016 Jan; 72(1):29-37. PubMed ID: 26423622 [TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetics of vancomycin and dosing recommendations for trauma patients. Medellín-Garibay SE; Ortiz-Martín B; Rueda-Naharro A; García B; Romano-Moreno S; Barcia E J Antimicrob Chemother; 2016 Feb; 71(2):471-9. PubMed ID: 26568565 [TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetics of continuous-infusion meropenem in a pediatric patient receiving extracorporeal life support. Cies JJ; Moore WS; Dickerman MJ; Small C; Carella D; Chopra A; Parker J Pharmacotherapy; 2014 Oct; 34(10):e175-9. PubMed ID: 25146254 [TBL] [Abstract][Full Text] [Related]
54. Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulation. Lim HS; Chong YP; Noh YH; Jung JA; Kim YS J Clin Pharm Ther; 2014 Apr; 39(2):196-203. PubMed ID: 24428720 [TBL] [Abstract][Full Text] [Related]
55. Population Pharmacokinetic Analysis of Gentamicin in Pediatric Extracorporeal Membrane Oxygenation. Moffett BS; Morris J; Galati M; Munoz FM; Arikan AA Ther Drug Monit; 2018 Oct; 40(5):581-588. PubMed ID: 29957666 [TBL] [Abstract][Full Text] [Related]
56. Non steady state and steady state PKS Bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients. Polard E; Le Bouquin V; Le Corre P; Kérebel C; Trout H; Feuillu A; Le Verge R; Mallédant Y Ther Drug Monit; 1999 Aug; 21(4):395-403. PubMed ID: 10442692 [TBL] [Abstract][Full Text] [Related]
57. Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine models. Shekar K; Roberts JA; Barnett AG; Diab S; Wallis SC; Fung YL; Fraser JF Crit Care; 2015 Dec; 19():437. PubMed ID: 26667471 [TBL] [Abstract][Full Text] [Related]
58. Population Pharmacokinetics of Vancomycin in Postoperative Neurosurgical Patients. Li X; Wu Y; Sun S; Mei S; Wang J; Wang Q; Zhao Z J Pharm Sci; 2015 Nov; 104(11):3960-3967. PubMed ID: 26239933 [TBL] [Abstract][Full Text] [Related]
59. Impact of vancomycin protein binding on target attainment in critically ill children: back to the drawing board? De Cock PA; Desmet S; De Jaeger A; Biarent D; Dhont E; Herck I; Vens D; Colman S; Stove V; Commeyne S; Vande Walle J; De Paepe P J Antimicrob Chemother; 2017 Mar; 72(3):801-804. PubMed ID: 27999035 [TBL] [Abstract][Full Text] [Related]
60. Population Pharmacokinetics of Levosimendan and its Metabolites in Critically Ill Neonates and Children Supported or Not by Extracorporeal Membrane Oxygenation. Bourgoin P; Lecomte J; Oualha M; Berthomieu L; Pereira T; Davril E; Lamoureux F; Joram N; Chenouard A; Duflot T Clin Pharmacokinet; 2023 Feb; 62(2):335-348. PubMed ID: 36631687 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]